Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Other Accumulated Expenses (2019 - 2021)

Historic Other Accumulated Expenses for Cresco Labs (CRLBF) over the last 3 years, with Q3 2021 value amounting to -$91000.0.

  • Cresco Labs' Other Accumulated Expenses fell 963.86% to -$91000.0 in Q3 2021 from the same period last year, while for Sep 2021 it was -$91000.0, marking a year-over-year decrease of 963.86%. This contributed to the annual value of -$1.1 million for FY2020, which is 13689.42% down from last year.
  • According to the latest figures from Q3 2021, Cresco Labs' Other Accumulated Expenses is -$91000.0, which was down 963.86% from -$52000.0 recorded in Q2 2021.
  • Over the past 5 years, Cresco Labs' Other Accumulated Expenses peaked at $3.0 million during Q4 2019, and registered a low of -$1.9 million during Q1 2020.
  • For the 3-year period, Cresco Labs' Other Accumulated Expenses averaged around -$51714.3, with its median value being -$91000.0 (2021).
  • Per our database at Business Quant, Cresco Labs' Other Accumulated Expenses plummeted by 13689.42% in 2020 and then surged by 9008.04% in 2021.
  • Over the past 3 years, Cresco Labs' Other Accumulated Expenses (Quarter) stood at $3.0 million in 2019, then tumbled by 136.89% to -$1.1 million in 2020, then soared by 91.87% to -$91000.0 in 2021.
  • Its Other Accumulated Expenses was -$91000.0 in Q3 2021, compared to -$52000.0 in Q2 2021 and -$185000.0 in Q1 2021.